| Study to Evaluate Subject Satisfaction With Facial Appearance and Impact of Combined Facial Treatment (NCT04609020) | Allergan | 2023-02-15 |
| A Study to Assess Adverse Events and Change in Disease Activity of HArmonyCa Lidocaine Injectable Gel for Mid Face Soft Tissue Augmentation in Adult Participants (NCT05452070) | Allergan | 2022-09-02 |
| Study of AGN-190584 Eye Drops to Assess Safety and Efficacy in Participants Aged 40-80 Years With Pseudophakic Presbyopia (NCT05393089) | Allergan | 2022-06-09 |
| A Study To Assess the Adverse Effects and Change in Condition of OnabotulinumtoxinA X Injection in Adult Participants With Forehead Lines (NCT05152576) | Allergan | 2021-11-29 |
| Study to Assess Effectiveness and Adverse Events of JUVEDERM VOLBELLA With Lidocaine Injection in Correcting Infraorbital Hollowing in Chinese Adult Participants (NCT05088980) | Allergan | 2021-10-19 |
| A Study to the Assess the Change in Condition and Adverse Events of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines (NCT05100199) | Allergan | 2021-10-06 |
| VFORM: Prospective, Open Label, Study to Evaluate VOLIFT With Lidocaine Treatment for FORehead Contouring and Marionette Lines (NCT05077488) | Allergan | 2021-09-15 |
| A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily (NCT04983589) | Allergan | 2021-09-02 |
| A Study of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines (NCT05013424) | Allergan | 2021-09-01 |
| Study to Assess Adverse Events (AEs) When Oral Atogepant Tablet is Given to Adult Chinese Participants Who Completed Study 3101-303-002 to Prevent Chronic Migraine (NCT04829747) | Allergan | 2021-08-02 |
| JUVÉDERM® VOLUMA® With Lidocaine for Correction of Temple Hollowing in Chinese Population (NCT04891419) | Allergan | 2021-07-20 |
| CoolSculpting® Elite for Non-Invasive Fat Reduction (NCT04897867) | Allergan | 2021-05-18 |
| Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments. (NCT04740827) | Allergan | 2021-03-05 |
| 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) (NCT04647214) | Allergan | 2021-03-03 |
| A Study of JUVÉDERM VOLUX® Injectable Gel for Chin Enhancement in Chinese Adults Using Real-World Evidence (NCT04687046) | Allergan | 2021-02-04 |
| Evaluation of Age-related Skin Changes Using Clinical Probe Measurements and Imaging Modalities in Chinese Subjects (NCT04655300) | Allergan | 2021-01-16 |
| Intradermal (ID) BOTOX in the Treatment of Facial Fine Lines (NCT04631588) | Allergan | 2020-11-16 |
| A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Patients in Canada (NCT04567095) | Allergan | 2020-10-31 |
| A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Healthcare Professionals in Canada (NCT04567589) | Allergan | 2020-09-30 |
| Evaluation of Age-related Skin Changes and Instrument Reliability Using Clinical Probe Measurements and Imaging Modalities (NCT04552249) | Allergan | 2020-09-22 |
| Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease (NCT04393441) | Allergan | 2020-06-29 |
| A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old (NCT04414397) | Allergan | 2020-05-28 |
| A Study to Evaluate the Effect of Juvederm Volift With Lidocaine on Aging Hands in Participants Age 35 and Older (NCT04390581) | Allergan | 2020-05-20 |
| A Study to Evaluate Androderm®'s Effect on Blood Pressure in Adult Hypogonodal Male Participants (NCT04320745) | Allergan | 2020-05-19 |
| A Retrospective Chart Review Study to Evaluate Safety of McGhan Single Lumen Gel-Filled Breast Implants in Patients in China (NCT04261608) | Allergan | 2020-04-02 |
| Real-world Evidence Study of XEN in Chinese Patients With Refractory Glaucoma (NCT04303897) | Allergan | 2019-12-19 |
| Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation (NCT04110145) | Allergan | 2019-10-14 |
| A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants (NCT04124705) | Allergan | 2019-10-11 |
| A Study to Evaluate The Impact on Skin Quality Attributes by Juvederm® Volite Injection on Healthy Volunteers (NCT04206293) | Allergan | 2019-10-08 |
| A Study to Evaluate the Effectiveness and Safety of OZURDEX® in Patients With Diabetic Macular Edema But Never Treated (NCT03953807) | Allergan | 2019-09-05 |
| International CoolSculpting: Study to Evaluate Patient Satisfaction for Non-Invasive Fat Reduction in Abdomen and/or Flanks (iCOOL) (NCT03909100) | Allergan | 2019-07-29 |
| Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China (NCT03908307) | Allergan | 2019-07-25 |
| Goblet Cell Degranulation Produced by Intranasal Tear Neurostimulator (ITN) in Dry Eye Disease (NCT03827564) | Allergan | 2019-06-24 |
| BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence (NCT03861936) | Allergan | 2019-05-16 |
| Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine (NCT03939312) | Allergan | 2019-05-06 |
| BOTOX® for the Treatment of Platysma Prominence (NCT03915067) | Allergan | 2019-04-23 |
| Evaluation of Age-Related Skin Changes (NCT03842566) | Allergan | 2019-04-18 |
| Chart Review of XEN 45 Gel Stent: Long Term Performance and Safety Assessment (XEN LT) (NCT03868254) | Allergan | 2019-04-05 |
| Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine (NCT03855137) | Allergan | 2019-03-11 |
| A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia (NCT03857542) | Allergan | 2019-03-01 |
| Satisfaction With XEN Gel Stent Versus Trabeculectomy for the Treatment of Glaucoma (NCT03852810) | Allergan | 2019-02-25 |
| A Study to Evaluate Participant Satisfaction With Facial Appearance Overall and the Aesthetic and Psychosocial Impact of Combined Facial Treatment (NCT03712449) | Allergan | 2019-01-22 |
| Chart Review: Drug Utilization Study in Participants Who Received Ozurdex™ (Dexamethasone Intravitreal Implant) 0.7 mg Injections for Visual Impairment Due to Diabetic Macular Edema (DME) (NCT03889444) | Allergan | 2019-01-15 |
| Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia (NCT03804268) | Allergan | 2018-12-21 |
| Diabetic Gastroparesis Study 05 (NCT03786380) | Allergan | 2018-12-20 |
| A Study to Evaluate the Effectiveness of Juvéderm® VOLIFT™ With Lidocaine for Lip Augmentation (NCT03796728) | Allergan | 2018-12-19 |
| 12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine (NCT03777059) | Allergan | 2018-12-14 |
| Dynamic Optical Coherence Tomography(D-OCT) Aging Study: A Preliminary Evaluation of Structural Differences Between Young and Aged Skin, Cellulite and Atrophic Acne Scars in Female Caucasian Subjects With Fitzpatrick Skin Types I-III Utilizing Non-invasive in Vivo D-OCT. (NCT03767400) | Allergan | 2018-12-07 |
| Study of the Safety and Effectiveness of JUVÉDERM VOLUX™ XC Injectable Gel for Restoring Jawline Definition (NCT03712137) | Allergan | 2018-11-12 |
| JUVÉDERM® VOLITE™ XC for Cheek Skin Smoothness (NCT03728309) | Allergan | 2018-11-09 |
| Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine (NCT03700320) | Allergan | 2018-10-08 |
| XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma: Gold-Standard Pathway Study (GPS) (NCT03654885) | Allergan | 2018-10-01 |
| A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease (NCT03316898) | Allergan | 2018-09-30 |
| Evaluation of the Safety and Effectiveness of BELKYRA® Inj. for the Treatment of Patients With Submental Fullness Due to Submental Fat: A Postmarketing Surveillance Study in Korea (NCT03691415) | Allergan | 2018-09-07 |
| Clinical Trial Evaluation of a Test Serum Post HEV (High Energy Visible) Light Exposure (NCT03594721) | Allergan | 2018-08-06 |
| Safety and Effectiveness of the XEN45 Glaucoma Treatment System in Patients With Angle Closure Glaucoma (NCT03362931) | Allergan | 2018-07-19 |
| Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric Patients (7-17 Years) With Major Depressive Disorder (NCT03569475) | Allergan | 2018-07-06 |
| Study to Evaluate Efficacy and Tolerability of Two Topical Regimens in Subjects With Moderate to Severe Facial Photodamage Who Have Received Cosmetic Injections (NCT03559972) | Allergan | 2018-06-04 |
| A Study to Evaluate Abicipar Pegol for Safety and Treatment Effect in Participants With Neovascular Age-related Macular Degeneration (AMD) (NCT03539549) | Allergan | 2018-05-25 |
| Study to Evaluate Botulinum Neurotoxin Serotype E (EB-001) in Reducing Musculoskeletal Pain in Abdominoplasty (NCT03429556) | Allergan | 2018-05-08 |
| Eluxadoline Bile Acid Malabsorption (BAM) Study (NCT03441581) | Allergan | 2018-02-23 |
| Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02 (NCT03426345) | Allergan | 2018-02-16 |
| A Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Cheek Augmentation Using Cannula (NCT03438266) | Allergan | 2018-02-05 |
| Physiopathologic Aspects and Quality of Life in Participants With Eye Dark Circles (NCT03400202) | Allergan | 2018-02-02 |
| Sequential Treatment With BELKYRA® Then Juvéderm® VOLUMA™ With Lidocaine for Overall Improvement in Jawline Contour (NCT03425253) | Allergan | 2018-02-02 |
| Safety and Effectiveness of JUVÉDERM® VOLUMA® With Lidocaine for Improvement of Volume and Aesthetic Appearance of the Nose in Chinese Adults (NCT03430986) | Allergan | 2018-02-02 |
| A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04 (NCT03383146) | Allergan | 2018-02-01 |
| A Safety and Effectiveness of VOLBELLA XC Hyaluronic Acid (HA) Injectable Gel to Correct Infraorbital Hollowing (NCT03418545) | Allergan | 2018-01-26 |
| A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03 (NCT03420781) | Allergan | 2018-01-24 |
| Open Label Study of BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Patients With Chronic Migraine (NCT03193359) | Allergan | 2018-01-15 |
| Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Japanese Patients With Neovascular AMD (NCT03335852) | Allergan | 2017-11-28 |
| Clinical Trial to Evaluate the Symptoms in Symptomatic Contact Lens Wearers Following Application of Intranasal Tear Neurostimulator Versus Control (NCT03325673) | Allergan | 2017-11-22 |
| Histological and Microbiological Evaluation of Late Occurring Nodules With Hyaluronic Acid Dermal Fillers (NCT03425721) | Allergan | 2017-11-21 |
| Efficacy of Ozurdex® in the Treatment of Diabetic Macular Edema (DME) (NCT03003416) | Allergan | 2017-10-19 |
| Clinical Study to Evaluate Tear Characteristics Following Acute TrueTear™ Use (NCT03274999) | Allergan | 2017-10-18 |
| BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence (NCT03320850) | Allergan | 2017-10-04 |
| Study to Assess the Cosmetic Changes in the Facial Skin After Use of a Topical Retinoid Product in Participants With Moderate to Severe Photodamage (NCT03302559) | Allergan | 2017-09-18 |